WO1999041382A3 - Nouvelle interleukine 3 et ses utilisations - Google Patents

Nouvelle interleukine 3 et ses utilisations Download PDF

Info

Publication number
WO1999041382A3
WO1999041382A3 PCT/US1999/001484 US9901484W WO9941382A3 WO 1999041382 A3 WO1999041382 A3 WO 1999041382A3 US 9901484 W US9901484 W US 9901484W WO 9941382 A3 WO9941382 A3 WO 9941382A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel
nucleic acids
polypeptide sequences
interleukin
novel interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/001484
Other languages
English (en)
Other versions
WO1999041382A2 (fr
Inventor
Radoje T Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
John Ford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc filed Critical Hyseq Inc
Priority to AU28665/99A priority Critical patent/AU2866599A/en
Publication of WO1999041382A2 publication Critical patent/WO1999041382A2/fr
Publication of WO1999041382A3 publication Critical patent/WO1999041382A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5403—IL-3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des nouveaux acides nucléiques isolés dans une banque d'ADNc de tissu hépatosplénique foetal, et les nouvelles séquences polypeptidiques codées par ces acides nucléiques. Ces nouvelles séquences polynucléotidiques et polypeptidiques constituent une nouvelle Interleukine 3.
PCT/US1999/001484 1998-02-17 1999-02-17 Nouvelle interleukine 3 et ses utilisations Ceased WO1999041382A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU28665/99A AU2866599A (en) 1998-02-17 1999-02-17 A novel interleukin-3 and uses thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2482098A 1998-02-17 1998-02-17
US09/024,820 1998-02-17
US17746798A 1998-10-23 1998-10-23
US09/177,467 1998-10-23
US20953498A 1998-12-11 1998-12-11
US09/209,534 1998-12-11

Publications (2)

Publication Number Publication Date
WO1999041382A2 WO1999041382A2 (fr) 1999-08-19
WO1999041382A3 true WO1999041382A3 (fr) 1999-12-16

Family

ID=27362396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/001484 Ceased WO1999041382A2 (fr) 1998-02-17 1999-02-17 Nouvelle interleukine 3 et ses utilisations

Country Status (2)

Country Link
AU (1) AU2866599A (fr)
WO (1) WO1999041382A2 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004691A1 (fr) * 1986-12-16 1988-06-30 Gist-Brocades N.V. Clonage et expression moleculaires d'il-3 humaine
WO1988005469A1 (fr) * 1987-01-20 1988-07-28 Immunex Corporation Proteines humaines il-3
EP0285429A2 (fr) * 1987-03-31 1988-10-05 Ube Industries, Ltd. Cellules produisant de l'interleukine-3 et procédé de preparation d'interleukine-3
WO1990010705A2 (fr) * 1989-03-15 1990-09-20 Gist-Brocades N.V. Production et purification d'interleukine-3 humaine de recombinaison et de ses muteines
WO1992006116A1 (fr) * 1990-09-28 1992-04-16 Ortho Pharmaceutical Corporation Facteurs de croissance hybride
WO1993012805A1 (fr) * 1992-01-02 1993-07-08 Regents Of The University Of Michigan Procede de regulation des lignages cellulaires humains hematopoeïtiques
WO1995020977A1 (fr) * 1994-02-04 1995-08-10 G.D. Searle & Co. Administration conjointe de polypeptides mutants d'interleukine-3 et de facteurs stimulant les colonies pour produire des cellules hematopoietiques multilignee

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004691A1 (fr) * 1986-12-16 1988-06-30 Gist-Brocades N.V. Clonage et expression moleculaires d'il-3 humaine
WO1988005469A1 (fr) * 1987-01-20 1988-07-28 Immunex Corporation Proteines humaines il-3
EP0285429A2 (fr) * 1987-03-31 1988-10-05 Ube Industries, Ltd. Cellules produisant de l'interleukine-3 et procédé de preparation d'interleukine-3
WO1990010705A2 (fr) * 1989-03-15 1990-09-20 Gist-Brocades N.V. Production et purification d'interleukine-3 humaine de recombinaison et de ses muteines
WO1992006116A1 (fr) * 1990-09-28 1992-04-16 Ortho Pharmaceutical Corporation Facteurs de croissance hybride
WO1993012805A1 (fr) * 1992-01-02 1993-07-08 Regents Of The University Of Michigan Procede de regulation des lignages cellulaires humains hematopoeïtiques
WO1995020977A1 (fr) * 1994-02-04 1995-08-10 G.D. Searle & Co. Administration conjointe de polypeptides mutants d'interleukine-3 et de facteurs stimulant les colonies pour produire des cellules hematopoietiques multilignee

Also Published As

Publication number Publication date
WO1999041382A2 (fr) 1999-08-19
AU2866599A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
ZA200007014B (en) Process for the hydroformylation of olefins.
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075067A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
ZA200006513B (en) Process for the preparation of aldehydes from olefins by hydroformylation.
EP0397633A3 (fr) Protéine liant la fibronectine et sa préparation
EP1308459A3 (fr) Séquences d'ADN complementaires pleine longueur
HUP9904348A3 (en) Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid
EP2006300A3 (fr) Caractérisation d'une famille du canal calcique
WO2001002571A3 (fr) Nouvel antagoniste du recepteur d'interleukin-1 et ses utilisations
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
WO1999051744A3 (fr) Antagoniste du recepteur de l'interleukine-1 et ses utilisations
AU7689696A (en) Dna sequence encoding the tumor suppressor ing1
WO2003022868A3 (fr) Proteines pouvant se lier avec des metaux et procedes associes
WO2002044340A3 (fr) Nouveaux acides nucleiques et polypeptides
CA2071950A1 (fr) Proteine fixatrice du collagene et sa preparation
AU2615999A (en) Process for the preparation of cefpodoxime proxetil diastereoisomers
WO1999041382A3 (fr) Nouvelle interleukine 3 et ses utilisations
GB9926986D0 (en) Process for the preparation of d,l-menthol
WO2001053453A8 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase